Read + download the full collection of #ASGCTBreakthroughs24 abstracts ahead of our inaugural muscular dystrophy conference Nov. 19-20.
Acknowledging early-career scientists who are members of underrepresented populations in science
Mavis Agbandje-McKenna, PhD, was a world-class scientist who advanced the field of gene therapy, a great mentor, and a recipient of ASGCT's Outstanding Achievement Award. She passed away in 2021 after a long battle with amyotrophic lateral sclerosis (ALS). Dr. Agbandje-McKenna's loss was felt deeply throughout the Society and the field.
Credit: University of Florida
In 2022, ASGCT introduced the Mavis Agbandje-McKenna Scholarship and Fund to honor the scholar's dedication to scientific excellence, love for mentoring others, and unending willingness to collaborate.
The permanent scholarship seeks to continue Dr. Agbandje-McKenna's legacy through ASGCT and focuses on identifying early-career researchers who are also members of underrepresented populations in science and provide the financial resources necessary to eliminate all barriers to participating in ASGCT.
By supporting this fund, you can help:
Donate to the Mavis Agbandje-McKenna Scholarship and Fund today
November 19-20, 2024 | Chicago, IL
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico